In this episode, we bring you clips from the best Blood & Cancer shows of 2020. Blood & Cancer will be back with new episodes in 2021. ESMO 2020: Late-breaking and practice-changing studies on COVID-19 and breast, lung, gastrointestinal, and other cancers https://bit.ly/3h7aWZM Beyond the lungs: How COVID-19 affects the blood, brain, gastrointestinal system, and other organ systems https://bit.ly/37GhV8Q EHA25: AML, myeloma, polycythemia vera, and COVID-19 with EHA President John Gribben https://bit.ly/3nS4592 VTE rate, 'COVID toes,' and Virchow's triad: What you need to know about COVID and coagulation https://bit.ly/3rizmnM ASCO 2020: Practice-changing studies in breast, lung, colorectal, and other cancers https://bit.ly/37EIbkg * * * For more MDedge Podcasts, go to mdedge.com/podcasts Email the show: [email protected] Interact with us on Twitter: @MDedgehemonc David Henry on Twitter: @davidhenrymd

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related